Sector: MedicalLa Jolla Pharmaceutical Company (NASDAQ: LJPC)
Headlines
- RidgewaterEquity.com Free Fundamental Sector & Market Research on GOLD, QCOR, LJPC, AMKR, FLIR and OREX
Nov 18, 2009 06:44 AM | AMKR, LJPC
- La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
Nov 16, 2009 05:00 PM | LJPC
- La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
Nov 09, 2009 06:58 PM | LJPC
- La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
Nov 02, 2009 03:00 PM | LJPC
- La Jolla Pharmaceutical Company to Seek Stockholder Approval of Dissolution
Oct 14, 2009 10:43 PM | LJPC
- InvestorSoup.com Issues Technical Trading Outlook for Opexa Therapeutics Inc.
Sep 14, 2009 06:51 AM | BIIB, LJPC, NVS, OPXA
- Mixed Earnings Signals
Apr 23, 2008 09:46 AM | AAPL, ABK, ACGY, ANAD, ASML, BRCM
- The Week's Insider Buys - Mar 15 2008 6:14PM
Mar 15, 2008 06:14 PM | BLDR, CBON, CDL, GE, ILA, LGF
- La Jolla Pharma Names Caviar Financial Chief
May 10, 2007 05:34 PM | AGN, LJPC
- La Jolla Pharma Names Caviar Financial Chief
May 10, 2007 05:34 PM | AGN, LJPC
- La Jolla Pharmaceutical Company Announces the Adjournment of Special Meeting of Stockholders
Nov 25, 2009 03:51 PM | LJPC
- La Jolla Pharmaceutical Company Receives Notice of Noncompliance With Nasdaq Stock Market Listing Requirement
Sep 18, 2009 05:09 PM | LJPC
- BenchmarkJournal.Com Free Analyst Review for SQM, RY, ALGT, UTIW, SPPI and LJPC
Jul 07, 2009 10:27 AM | ALGT, LJPC, RY, SPPI, SQM, UTIW
- La Jolla Pharmaceutical Company Announces Going Concern Opinion and Receipt of Nasdaq Staff Deficiency Letter
Apr 08, 2009 06:42 PM | LJPC
- La Jolla Pharmaceutical Company Announces Reduction in Workforce and Evaluates Strategic Options
Feb 19, 2009 03:36 PM | LJPC
- La Jolla Pharmaceutical Company Announces Negative Results of Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial
Feb 12, 2009 07:34 AM | LJPC
- La Jolla Pharmaceutical Company to Present at BIO CEO & Investor Conference
Feb 05, 2009 07:32 AM | LJPC
- BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
Jan 06, 2009 04:31 PM | BMRN, LJPC
- La Jolla Pharmaceutical Provides Update on Its Auction Rate Securities and Its Ongoing Riquent® Phase 3 “ASPEN” Lupus Trial
Dec 18, 2008 07:33 AM | LJPC
- La Jolla Pharmaceutical Company Reports Third Quarter and Year-to-Date Financial Results
Oct 31, 2008 07:31 AM | LJPC
- Form 4 LA JOLLA PHARMACEUTICAL For: Aug 05 Filed by: SUTTER MARTIN P (10K)
Aug 07, 2009 06:24 PM
- Form 4 LA JOLLA PHARMACEUTICAL For: Aug 05 Filed by: ESSEX WOODLANDS HEALTH VENTURES FUND VII LP (10K)
Aug 07, 2009 06:22 PM
- Form 4 ESSEX WOODLANDS HEALTH For: Aug 05 (10K)
Aug 07, 2009 06:22 PM
- Form 4 SLOAN GAIL A For: Aug 06 (10K)
Aug 07, 2009 05:29 PM
- Form 4 LA JOLLA PHARMACEUTICAL For: Jul 31 Filed by: SUTTER MARTIN P (10K)
Aug 04, 2009 07:28 PM
- Form 4 SLOAN GAIL A For: Jun 25 (10K)
Jun 25, 2009 09:46 PM
- Form 4 LA JOLLA PHARMACEUTICAL For: Jun 17 Filed by: BIOMARIN PHARMACEUTICAL INC (10K)
Jun 19, 2009 10:04 PM
- Form 4 LA JOLLA PHARMACEUTICAL For: Mar 27 Filed by: BIOMARIN PHARMACEUTICAL INC (10K)
Jun 19, 2009 10:00 PM
- Form 4 SLOAN GAIL A For: Jun 18 (10K)
Jun 19, 2009 07:05 PM
- Form 4 Elchico Josefina T For: Feb 24 (10K)
Mar 05, 2009 04:29 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
LJPC
|
Compare to S&P
|
| YTD |
-88.45 %
|
-90.44 %
|
| 4 Weeks |
-15.19 %
|
-16.10 %
|
| 12 Weeks |
-69.54 %
|
-71.29 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 62.50 %
|
|
EPS Growth in Last Year: 90.32 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
